A-Alpha Bio, David Baker Lab Spinout, Launches Consortium to Generate Data for AI-Made Antibodies
GabriCorso · x · 2026-07-22
A-Alpha Bio, a spinout from David Baker's lab, is debuting a new consortium to collectively generate data for AI-made antibodies. CEO David Younger said, "The amount of data that's going to be needed to solve these problems is massive."
More from Research
- AI slop is already clogging PR review and weakening the credit system behind science — rbhar90 · 2026-07-27
- ICML 2026 oral paper replication scores stay middling after a stricter re-scoring — profjamesevans · 2026-07-27
- Long-running agents will need immutable event logs, this thread argues — sebpaquet · 2026-07-27
- Seed IQ navigates Doom II, prompting questions about benchmarks beyond ARC-AGI — Fit_Transition8824 · 2026-07-27
- Agentic Data Science in Practice: Agents Write Code but Answer Wrong Questions — hugobowne · 2026-07-27
- A concise canon of foundational papers in ML, systems, NLP, speech, and audio — deliprao · 2026-07-27